Trugman J M, Geary W A, Wooten G F
Nature. 1986;323(6085):267-9. doi: 10.1038/323267a0.
Recent work with positron emission and single photon emission computed tomography has demonstrated the feasibility of studying striatal dopamine receptors in the living human brain. For the proper interpretation of these studies in normal and diseased states, the cellular localization of these receptors must be definitively established. It has been claimed, on the basis of receptor binding studies with tissue homogenates in rats, that 30-50% of striatal D-2 dopamine receptors are located on axons or terminals of the corticostriatal pathway. This finding has been incorporated into major reviews and classifications of dopamine receptors. The recent development of quantitative autoradiographic methods for diffusible ligands has facilitated the study of neurotransmitter receptors in cytoarchitechtonically intact tissue. Because this technique provides the necessary anatomic resolution that is lacking in homogenate binding studies, we have used it to re-examine the localization of striatal dopamine receptors. Here we present evidence that D-2 receptors are located exclusively on kainic acid-sensitive intrinsic neuronal elements in the striatum. We report that discrete cortical ablation does not alter 3H-spiperone binding to rat striatum and thus our results do not support the existence of D-2 dopamine receptors on the terminals of the corticostriatal pathway.
近期关于正电子发射断层扫描和单光子发射计算机断层扫描的研究已证明,在活体人类大脑中研究纹状体多巴胺受体是可行的。为了在正常和疾病状态下正确解读这些研究,必须明确这些受体的细胞定位。基于对大鼠组织匀浆进行的受体结合研究,有人声称纹状体中30%至50%的D-2多巴胺受体位于皮质纹状体通路的轴突或终末上。这一发现已被纳入多巴胺受体的主要综述和分类中。用于可扩散配体的定量放射自显影方法的最新进展促进了在细胞结构完整的组织中对神经递质受体的研究。由于该技术提供了匀浆结合研究中所缺乏的必要解剖分辨率,我们利用它重新审视了纹状体多巴胺受体的定位。在此,我们提供证据表明,D-2受体仅位于纹状体中对 kainic 酸敏感的内在神经元成分上。我们报告,离散的皮质切除不会改变3H-螺哌隆与大鼠纹状体的结合,因此我们的结果不支持皮质纹状体通路终末上存在D-2多巴胺受体。